Radiolabeled derivatives of Tyr3-octreotide and Tyr3-octreotate, synthetic analogues of the
peptide hormone somatostatin, can be used for positron emission tomography (PET) …

A monoreactive NOTA (1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid) derived prochelator
(1-(1-carboxy-3-carbo-tert-butoxypropyl)-4, 7-(carbo-tert-butoxymethyl)-1, 4, 7 …

Somatostatin‐based radioligands have been shown to have sensitive imaging properties for
neuroendocrine tumours and their metastases. The potential of [55Co (dotatoc)](dotatoc= 4 …

The bifunctional chelator and radiometal have been shown to have a direct effect on the
pharmacokinetics of somatostatin receptor (SSTR)-targeted imaging agents. We evaluated …

Radiolabeled somatostatin analogs have become powerful tools in the diagnosis and
staging of neuroendocrine tumors, which express somatostatin receptors. The aim of this …

Short synthetic octapeptide analogs derived from the native somatostatin peptides SST-14
and SST-28, namely, octreotate (TATE) or octreotide (TOC), bind with high affinity to …

Somatostatin receptors (SSTr) are overexpressed in a wide range of neuroendocrine
tumors, making them excellent targets for nuclear imaging and therapy, and radiolabeled …

Purpose Somatostatin receptors (SSTR) have been reported as promising targets for
imaging agents for cancer. Recently, 68 Ga-DOTATOC-based PET imaging has been used …

Somatostatin-derived analogues play an important role in the diagnosis and treatment of
neuroendocrine tumors. The aim of this study was to evaluate a new somatostatin analogue …

Radionuclide labeled somatostatin analogues selectively target somatostatin receptor
(SSTR)-expressing tumors as a basis for diagnosis and treatment of these tumors. Recently …